Studies have shown that patients with anti-nephrin-associated MCD have a more fulminant NS and a better response to antibody-depleting therapy than those who are anti-nephrin-negative.<h4>Materials and methods</h4>We report cases of a 79- and a 42-year-old male patient presenting with new-onset NS and acute kidney injury. This evidence concerns the gene NPHS1 and acute kidney injury.